Pay in 4 interest-free payments of $25.00 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
CASIN-treated HSCs were further shown to engraft long term in vivo with enhanced repopulation ability
88(1-2):1-9
Engstler BS
InChi: InChI=1S/C15H12F2N6O3S/c16-10-2-1-3-11(17)12(10)13(24)23-14(18)21-15(22-23)20-8-4-6-9(7-5-8)27(19
12-tetraoxatetradecanamido)-2-(((R)-1
LY2606368 dihydrochloride or® 526 SE CASIN-treated HSCs were further shownPrexasertib, also known as LY2606368, is a potent and selective Chk1 Chk2 inhibitor. Prexasertib increases the effectiveness of conventional therapy in B T cell progenitor acute lymphoblastic leukemia. LY2606368 Causes Replication Catastrophe and Antitumor Effects through CHK1 Dependent Mechanisms. Treatment of cells with LY2606368 results in the rapid appearance of TUNEL and pH2AX positive double stranded DNA breaks in the S phase cell population.
US$ 25.00
US$ 11.00
US$ 11.00
US$ 20.00
US$ 22.00
US$ 11.00
US$ 30.00
US$ 22.00
US$ 14.00
US$ 11.00
US$ 11.00
US$ 11.00
US$ 11.00
US$ 25.00
US$ 32.00
US$ 12.00
US$ 18.00
US$ 20.00
US$ 16.00